Over $100 billion in name brand drugs are coming off patent soon, according to the most recent tally, with 2010-2012 becoming the critical period for generics. Growth in demand for generics has also boosted Medco's business, according to CEO David Snow.
Bloomberg - (BLOOM)
Feb. 21, 2007. 01:48 PM EST